Looking forward to participating in the @aseica.bsky.social - ASPIC Meeting, where I’ll be discussing the role of oncolytic viruses in immune activation in breast cancer. Grateful for the invitation and the opportunity to exchange ideas with such an outstanding scientific community.

Analysis of residual disease specimens is challenging - but a fascinating study pooling 4 HER2+ clinical trials! @oncoalert.bsky.social @tomaspascualmd.bsky.social www.sciencedirect.com/science/arti...